Table 3.

Laboratory and clinical characteristics of SLE patients.

Parameters	M ± SE	Parameters	No [%]	Parameters	No [%]
Disease duration [months]	7.21 ± 0.53	Malar rash	82 [73%]	Nonscarring Alopecia	34 [30%]
Female/Male	103/10	Photosensitivity	60 [54%]	Thrombocytopenia	27 [24%]
Total SLEDAI	9.28 ± 0.73	Oral Ulcers	57 [51%]	Hemolytic anemia	17 [15%]
Serum albumin	3.32 ± .077	Arthritis	63 [56%]	Leucopenia	34 [30%]
C3 titter [mg/dl]	65.10 ± 6.60	Serositis	45 [40%]	Neutropenia	18 [16%]
C4 titter [mg/dl]	32.98 ± 4.46	Renal disorders	53 [47%]	Lymphopenia	35 [31%]
		Neuropsychiatric disorders	14 [12%]
Treatment	No [%]	Pancytopenia	26 [23%]
Corticosteroid	91 [81%]	Anti-nuclear antibodies	85 [75%]
Hydroxychloroquine	95 [84%]	Anti-dsDNA antibodies	76 [67%]
Cyclophosphamide	54 [48%]	Anti-phospholipid syndrome [APS]	22 [19%]
Azathioprine	71 [63%]	Mucocutaneous manifestation	93 [83%]
Biologic	5 [4%]